These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 25586399)

  • 1. Repeated administration of aripiprazole produces a sensitization effect in the suppression of avoidance responding and phencyclidine-induced hyperlocomotion and increases D2 receptor-mediated behavioral function.
    Gao J; Qin R; Li M
    J Psychopharmacol; 2015 Apr; 29(4):390-400. PubMed ID: 25586399
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-lasting sensitization induced by repeated risperidone treatment in adolescent Sprague-Dawley rats: a possible D2 receptor mediated phenomenon?
    Qiao J; Gao J; Shu Q; Zhang Q; Hu G; Li M
    Psychopharmacology (Berl); 2014 Apr; 231(8):1649-1659. PubMed ID: 24363078
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sex differences in aripiprazole sensitization from adolescence to adulthood.
    Freeman E; Lin J; Chow S; Davis C; Li M
    Pharmacol Biochem Behav; 2017 May; 156():39-47. PubMed ID: 28389140
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Repeated asenapine treatment produces a sensitization effect in two preclinical tests of antipsychotic activity.
    Qin R; Chen Y; Li M
    Neuropharmacology; 2013 Dec; 75():356-64. PubMed ID: 23954676
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Repeated effects of the neurotensin receptor agonist PD149163 in three animal tests of antipsychotic activity: assessing for tolerance and cross-tolerance to clozapine.
    Chou S; Davis C; Jones S; Li M
    Pharmacol Biochem Behav; 2015 Jan; 128():78-88. PubMed ID: 25433325
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Time-dependence of risperidone and asenapine sensitization and associated D2 receptor mechanism.
    Gao J; Li M
    Behav Brain Res; 2013 Nov; 257():286-94. PubMed ID: 24103641
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Asenapine sensitization from adolescence to adulthood and its potential molecular basis.
    Shu Q; Qin R; Chen Y; Hu G; Li M
    Behav Brain Res; 2014 Oct; 273():166-76. PubMed ID: 25093543
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Contextual and behavioral control of antipsychotic sensitization induced by haloperidol and olanzapine.
    Zhang C; Li M
    Behav Pharmacol; 2012 Feb; 23(1):66-79. PubMed ID: 22157143
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Repeated antipsychotic treatment progressively potentiates inhibition on phencyclidine-induced hyperlocomotion, but attenuates inhibition on amphetamine-induced hyperlocomotion: relevance to animal models of antipsychotic drugs.
    Sun T; Hu G; Li M
    Eur J Pharmacol; 2009 Jan; 602(2-3):334-42. PubMed ID: 19059234
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adult response to olanzapine or clozapine treatment is altered by adolescent antipsychotic exposure: a preclinical test in the phencyclidine hyperlocomotion model.
    Shu Q; Hu G; Li M
    J Psychopharmacol; 2014 Apr; 28(4):363-75. PubMed ID: 24257809
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Time-dependent sensitization of antipsychotic effect in adolescent male and female rats.
    Ding X; Li X; Shu Q; Wu R; Hu G; Li M
    Behav Brain Res; 2017 Jun; 328():186-194. PubMed ID: 28412306
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neural basis of the potentiated inhibition of repeated haloperidol and clozapine treatment on the phencyclidine-induced hyperlocomotion.
    Zhao C; Sun T; Li M
    Prog Neuropsychopharmacol Biol Psychiatry; 2012 Aug; 38(2):175-82. PubMed ID: 22476004
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of Repeated Ropinirole Treatment on Phencyclidine-Induced Hyperlocomotion, Prepulse Inhibition Deficits, and Social Avoidance in Rats.
    Maple AM; Call T; Kimmel PC; Hammer RP
    J Pharmacol Exp Ther; 2017 Apr; 361(1):109-114. PubMed ID: 28167638
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distinct neural mechanisms underlying acute and repeated administration of antipsychotic drugs in rat avoidance conditioning.
    Li M; Sun T; Zhang C; Hu G
    Psychopharmacology (Berl); 2010 Sep; 212(1):45-57. PubMed ID: 20623111
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term impacts of adolescent risperidone treatment on behavioral responsiveness to olanzapine and clozapine in adulthood.
    Qiao J; Zhang Q; Li M
    Prog Neuropsychopharmacol Biol Psychiatry; 2014 Jan; 48():177-85. PubMed ID: 24140929
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dissociation between in vivo occupancy and functional antagonism of dopamine D2 receptors: comparing aripiprazole to other antipsychotics in animal models.
    Natesan S; Reckless GE; Nobrega JN; Fletcher PJ; Kapur S
    Neuropsychopharmacology; 2006 Sep; 31(9):1854-63. PubMed ID: 16319908
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Repeated administration of 5-hydroxytryptamine 2C agonist MK212 produces a sensitization effect of antipsychotic activity.
    Chen W; Wang X; Yan M; Wang Y; Xie S; Li H; Li M
    IUBMB Life; 2016 Dec; 68(12):985-993. PubMed ID: 27797140
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of central activation of serotonin 5-HT2A/2C or dopamine D 2/3 receptors on the acute and repeated effects of clozapine in the conditioned avoidance response test.
    Feng M; Gao J; Sui N; Li M
    Psychopharmacology (Berl); 2015 Apr; 232(7):1219-30. PubMed ID: 25288514
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Brexpiprazole II: antipsychotic-like and procognitive effects of a novel serotonin-dopamine activity modulator.
    Maeda K; Lerdrup L; Sugino H; Akazawa H; Amada N; McQuade RD; Stensbøl TB; Bundgaard C; Arnt J; Kikuchi T
    J Pharmacol Exp Ther; 2014 Sep; 350(3):605-14. PubMed ID: 24947464
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Olanzapine and risperidone disrupt conditioned avoidance responding in phencyclidine-pretreated or amphetamine-pretreated rats by selectively weakening motivational salience of conditioned stimulus.
    Li M; He W; Mead A
    Behav Pharmacol; 2009 Feb; 20(1):84-98. PubMed ID: 19179852
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.